CIK: 0002018299 · Show all filings
Period: Q4 2025 (← Previous)
Filing Date: Feb 17, 2026
Total Value ($000): $456,876 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| TERN | TERNS PHARMACEUTICALS INC | 375,000 | $15,150 | 3.3% | $23.11 | 0.0% | COM | 880881107 |
| PRAX | PRAXIS PRECISION MEDICINES I | 46,457 | $13,693 | 3.0% | $186.22 | 0.0% | COM NEW | 74006W207 |
| PALI | PALISADE BIO INC | 4,799,875 | $11,280 | 2.5% | $1.92 | 0.0% | COM | 696389402 |
| SRZN | SURROZEN INC | 416,150 | $9,405 | 2.1% | $16.18 | 0.0% | COM NEW | 86889P208 |
| CAPR | CAPRICOR THERAPEUTICS INC | 325,000 | $9,380 | 2.1% | $13.06 | 0.0% | COM NEW | 14070B309 |
| COGT | COGENT BIOSCIENCES INC | 225,000 | $7,992 | 1.7% | $28.11 | 0.0% | COM | 19240Q201 |
| HELP | CYBIN INC | 715,000 | $5,849 | 1.3% | $6.44 | 0.0% | COM NEW | 23256X407 |
| CTNM | CONTINEUM THERAPEUTICS INC | 494,000 | $5,646 | 1.2% | $11.41 | 0.0% | CL A | 21217B100 |
| GPCR | STRUCTURE THERAPEUTICS INC | 75,000 | $5,216 | 1.1% | $69.55 | — | SPONSORED ADS | 86366E106 |
| UPB | UPSTREAM BIO INC | 150,000 | $4,073 | 0.9% | $24.89 | 0.0% | COM | 91678A107 |
| VIR | VIR BIOTECHNOLOGY INC | 625,000 | $3,769 | 0.8% | $5.95 | 0.0% | COM | 92764N102 |
| IVVD | INVIVYD INC | 1,500,000 | $3,705 | 0.8% | $2.08 | 0.0% | COM | 00534A102 |
| KPTI | KARYOPHARM THERAPEUTICS INC | 252,536 | $1,859 | 0.4% | $6.12 | 0.0% | COM NEW | 48576U205 |
| CLNN | CLENE INC | 199,737 | $1,172 | 0.3% | $8.31 | 0.0% | COM NEW | 185634201 |
| ZURA | ZURA BIO LTD | 50,000 | $262 | 0.1% | $3.95 | 0.0% | CLASS A ORD SHS | G9TY5A101 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| KOD | KODIAK SCIENCES INC | 1,136,000 (+51.5%) | $31,763 (+158.7%) | 7.0% | $10.75 | +90.6% | COM | 50015M109 |
| CELC | CELCUITY INC | 225,000 (+150.0%) | $22,442 (+404.8%) | 4.9% | $65.33 | +25.8% | COM | 15102K100 |
| TNGX | TANGO THERAPEUTICS INC | 10,876,219 (+11.3%) | $96,363 (+17.4%) | 21.1% | $5.05 | +70.7% | COM | 87583X109 |
| KYMR | KYMERA THERAPEUTICS INC | 329,100 (+3.1%) | $25,607 (+41.8%) | 5.6% | $43.27 | +56.1% | COM | 501575104 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 170,000 (+54.5%) | $14,848 (+103.2%) | 3.2% | $62.54 | +30.9% | COM | 74366E102 |
| — | CIDARA THERAPEUTICS INC | 53,000 (+10.4%) | $11,707 (+154.7%) | 2.6% | $64.95 | — | COM NEW | 171757206 |
| ABVX | ABIVAX SA | 125,000 (+4.2%) | $16,857 (+65.5%) | 3.7% | $86.90 | — | SPONSORED ADS | 00370M103 |
| — | MIND MEDICINE MINDMED INC | 598,500 (+266.1%) | $8,014 (+315.7%) | 1.8% | $12.95 | — | COM NEW | 60255C885 |
| AVTX | AVALO THERAPEUTICS INC | 275,000 (+120.0%) | $4,994 (+214.3%) | 1.1% | $13.12 | +28.7% | COM NEW | 05338F306 |
| APGE | APOGEE THERAPEUTICS INC | 70,000 (+40.0%) | $5,284 (+166.0%) | 1.2% | $45.27 | +39.1% | COM | 03770N101 |
| PGEN | PRECIGEN INC | 1,375,000 (+61.8%) | $5,748 (+105.5%) | 1.3% | $3.22 | +20.1% | COM | 74017N105 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 275,000 (+10.0%) | $3,625 (+102.2%) | 0.8% | $48.45 | -75.7% | CLASS A ORD | 61559X104 |
| PEPG | PEPGEN INC | 373,892 (+49.6%) | $2,434 (+110.7%) | 0.5% | $2.80 | +85.5% | COM | 713317105 |
| INO | INOVIO PHARMACEUTICALS INC | 2,420,122 (+5.2%) | $4,211 (-21.8%) | 0.9% | $1.93 | +14.2% | COM SHS | 45773H409 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | MERUS N V | 120,000 | $11,298 | 2.5% | $42.05 | — | — | N5749R100 |
| NKTR | NEKTAR THERAPEUTICS | 125,000 | $7,113 | 1.6% | $11.24 | +398.1% | — | 640268306 |
| DNLI | DENALI THERAPEUTICS INC | 250,000 | $3,630 | 0.8% | $14.37 | +17.5% | — | 24823R105 |
| TIL | INSTIL BIO INC | 60,700 | $1,084 | 0.2% | $30.49 | -51.5% | — | 45783C200 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| QURE | UNIQURE NV | 290,000 (-63.7%) | $6,940 (-85.1%) | 1.5% | $9.43 | +309.1% | SHS | N90064101 |
| CYTK | CYTOKINETICS INC | 100,000 (-50.0%) | $6,354 (-42.2%) | 1.4% | $41.20 | +51.0% | COM NEW | 23282W605 |
| REPL | REPLIMUNE GROUP INC | 750,000 (-28.6%) | $7,290 (+65.7%) | 1.6% | $11.51 | -26.1% | COM | 76029N106 |
| AMLX | AMYLYX PHARMACEUTICALS INC | 800,000 (-11.1%) | $9,664 (-21.0%) | 2.1% | $4.71 | +188.7% | COM | 03237H101 |
| SLDB | SOLID BIOSCIENCES INC | 300,000 (-50.0%) | $1,692 (-54.3%) | 0.4% | $5.85 | -7.3% | COM NEW | 83422E204 |
| SRPT | SAREPTA THERAPEUTICS INC | 150,000 (-40.0%) | $3,228 (-33.0%) | 0.7% | $20.31 | +3.8% | COM | 803607100 |
| NRIX | NURIX THERAPEUTICS INC | 100,000 (-42.9%) | $1,897 (+17.3%) | 0.4% | $22.92 | -37.3% | COM | 67080M103 |
| URGN | UROGEN PHARMA LTD | 500,000 (-13.0%) | $11,710 (+2.1%) | 2.6% | $9.60 | +126.1% | COM | M96088105 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| RVMD | REVOLUTION MEDICINES INC | 400,000 | $31,860 | 7.0% | $50.47 | +29.9% | COM | 76155X100 |
| PTCT | PTC THERAPEUTICS INC | 200,000 | $15,192 | 3.3% | $52.09 | +39.5% | COM | 69366J200 |
| LBRX | LB PHARMACEUTICALS INC | 70,000 | $1,558 | 0.3% | $15.87 | +10.1% | COM SHS | 50180M108 |
| KALV | KALVISTA PHARMACEUTICALS INC | 20,400 | $329 | 0.1% | $12.23 | +8.3% | COM | 483497103 |
| — | NUVATION BIO INC | 266,666 | $88 | 0.0% | $0.23 | — | *W EXP 02/10/202 | 67080N119 |
| CBIO | CRESCENT BIOPHARMA INC. | 453,686 | $5,381 | 1.2% | $21.15 | -39.8% | COM | G2545C104 |
| MIST | MILESTONE PHARMACEUTICALS IN | 666,666 | $1,347 | 0.3% | $1.76 | +22.5% | COM | 59935V107 |
| SRZNW | SURROZEN INC | 66,666 | $1 | 0.0% | $0.02 | — | *W EXP 08/01/203 | 86889P117 |